Skip to content

Spinal Cord Electrical Stimulation for Low Back Pain and Gait Disorders in Advanced Parkinson's Disease: A Prospective Randomized Crossover Controlled Exploratory Clinical Trial

Spinal Cord Electrical Stimulation for Low Back Pain and Gait Disorders in Advanced Parkinson's Disease: A Prospective Randomized Crossover Controlled Exploratory Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129452
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late stage Parkinson's disease patients with lower back pain and gait disorders

Interventions

A group:Phase 1: 3-month 'active stimulation' mode ( true stimulation) Washout period: 4 weeks Phase 2: 3-month 'cross' stimulation pattern( false stimulation)
B group:Phase 1: 3-month 'active stimulation' mode ( false stimulation) Washout period: 4 weeks Phase 2: 3-month 'cross' stimulation pattern ( true stimulation) ( true stimulation)

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 50-75 years old. 2. Idiopathic Parkinson's disease that meets the clinical diagnostic criteria of the International Association of Motor Disorders, with Hoehn & Yahr staging in the "open stage" as III-IV. 3. The disease course is >= 5 years, and there is chronic (>= 6 months) moderate to severe back pain that is difficult to control with medication (NRS >= 4 points). 4. There is a clear "off period" gait disorder, manifested as frozen gait and/or postural instability (using a frozen gait questionnaire score of >= 10, or having a history of >= 1 fall in the past 3 months). 5. The optimal drug treatment regimen (including dopaminergic drugs) is stable for at least one month, and symptom control is still not ideal. 6. Cognitive function can be evaluated and treated in conjunction with Montreal Cognitive Assessment (MoCA >= 18 points). 7. Sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Secondary Parkinson's syndrome or atypical Parkinson's disease (such as multiple system atrophy, progressive supranuclear palsy); 2. There are spinal structural lesions that require priority surgical treatment, such as nerve root pain or lumbar spinal stenosis; 3. SCS or surgical contraindications (such as coagulation dysfunction, immunosuppression, systemic or local infections, inability to cooperate with MRI examination); 4. Accompanied by other serious or unstable internal medicine or psychiatric disorders; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Lower back pain index score;

Secondary

MeasureTime frame
Laboratory gait analysis;Stand up walking test;Quality of Life;

Countries

China

Contacts

Public ContactHongyu Zhou

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

iamrains@hotmail.com+86 21 6838 3127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026